Catalyst Event
Livzon Pharmaceutical Group Inc (1513) · Other
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
5/11/2026, 12:00:00 AM
Completion of the public tender offer for Vietnam's Imexpharm Corporation (IMP) on May 11, 2026, securing a controlling stake of approximately 67.88% of voting shares. Low importance estimated as the market impact is expected to be limited, scheduled.
Korean Translation
2026년 5월 11일 베트남 Imexpharm Corporation(IMP)에 대한 공개매수 완료 및 의결권 기준 약 67.88%의 지배 지분 확보 예정임. 시장 영향이 제한적일 것으로 판단되어 낮은 중요도로 예정됨.
Related Recent Events
JD Health International Inc (6618) · Earnings Release
Low importance estimated as no market reaction has occurred yet; Q2 2026 earnings report scheduled.
8/12/2026, 12:00:00 AM
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date on June 16, 2026, for the final dividend of RMB 1.43 per 10 shares, scheduled to be paid on July 13, 2026. Low importance estimated as the dividend amount is within historical norms, scheduled.
6/16/2026, 12:00:00 AM
Grand Pharmaceutical Group Ltd (512) · Other
Ex-dividend date (2026-06-12) for the proposed 2025 final dividend of HK$0.169 per share is scheduled.
6/12/2026, 12:00:00 AM
Veracyte Inc (VCYT) · Other
Annual Meeting of Stockholders on 2026-06-10, with proposals including the election of directors and an expansion of the 2023 Equity Incentive Plan scheduled.
6/10/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Pacific Biosciences of California Inc (PACB) · Other
The 2026 Annual Meeting of Stockholders is scheduled for June 3, 2026, including a proposal to increase the number of shares reserved for the 2020 Equity Incentive Plan by 16,000,000. A low impact is estimated due to potential share dilution, scheduled.
6/3/2026, 12:00:00 AM